These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

859 related items for PubMed ID: 24331779

  • 1. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
    Bagosi Z, Csabafi K, Palotai M, Jászberényi M, Földesi I, Gardi J, Szabó G, Telegdy G.
    Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779
    [Abstract] [Full Text] [Related]

  • 2. The interaction of Urocortin II and Urocortin III with amygdalar and hypothalamic cotricotropin-releasing factor (CRF)--reflections on the regulation of the hypothalamic-pituitary-adrenal (HPA) axis.
    Bagosi Z, Csabafi K, Palotai M, Jászberényi M, Földesi I, Gardi J, Szabó G, Telegdy G.
    Neuropeptides; 2013 Oct; 47(5):333-8. PubMed ID: 23932308
    [Abstract] [Full Text] [Related]

  • 3. The effects of the urocortins on the hypothalamic-pituitary-adrenal axis - similarities and discordancies between rats and mice.
    Bagosi Z, Csabafi K, Karasz G, Jászberényi M, Földesi I, Siska A, Szabó G, Telegdy G.
    Peptides; 2019 Feb; 112():1-13. PubMed ID: 30414887
    [Abstract] [Full Text] [Related]

  • 4. The effects of CRF and urocortins on the hippocampal glutamate release.
    Bagosi Z, Balangó B, Pintér D, Csabafi K, Jászberényi M, Szabó G, Telegdy G.
    Neurochem Int; 2015 Nov; 90():67-71. PubMed ID: 26216727
    [Abstract] [Full Text] [Related]

  • 5. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG, Patchev V, Vergalla J, Chrousos G, Jones EA.
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [Abstract] [Full Text] [Related]

  • 6. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
    Kakui N, Kitamura K.
    Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455
    [Abstract] [Full Text] [Related]

  • 7. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
    Smith SM, Vaughan JM, Donaldson CJ, Rivier J, Li C, Chen A, Vale WW.
    Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883
    [Abstract] [Full Text] [Related]

  • 8. The effects of corticotropin-releasing factor and the urocortins on hypothalamic gamma-amino butyric acid release--the impacts on the hypothalamic-pituitary-adrenal axis.
    Bagosi Z, Csabafi K, Jászberényi M, Telegdy G.
    Neurochem Int; 2012 Mar; 60(4):350-4. PubMed ID: 22306347
    [Abstract] [Full Text] [Related]

  • 9. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB, Fairhall KM, Robinson IC.
    Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
    [Abstract] [Full Text] [Related]

  • 10. Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons.
    Zelena D, Mergl Z, Makara GB.
    Brain Res; 2005 Jan 21; 1031(2):185-93. PubMed ID: 15649443
    [Abstract] [Full Text] [Related]

  • 11. Centrally administered murine-leptin stimulates the hypothalamus-pituitary- adrenal axis through arginine-vasopressin.
    Morimoto I, Yamamoto S, Kai K, Fujihira T, Morita E, Eto S.
    Neuroendocrinology; 2000 Jun 21; 71(6):366-74. PubMed ID: 10878498
    [Abstract] [Full Text] [Related]

  • 12. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
    Owens MJ, Knight DL, Ritchie JC, Nemeroff CB.
    J Pharmacol Exp Ther; 1991 Feb 21; 256(2):787-94. PubMed ID: 1847212
    [Abstract] [Full Text] [Related]

  • 13. Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats.
    Gil-Lozano M, Romaní-Pérez M, Outeiriño-Iglesias V, Vigo E, González-Matías LC, Brubaker PL, Mallo F.
    Endocrinology; 2014 Jul 21; 155(7):2511-23. PubMed ID: 24731096
    [Abstract] [Full Text] [Related]

  • 14. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R.
    J Neuroendocrinol; 1996 Aug 21; 8(8):579-85. PubMed ID: 8866244
    [Abstract] [Full Text] [Related]

  • 15. Stimulation of adrenocorticotropin secretion by insulin-induced hypoglycemia in the developing rat involves arginine vasopressin but not corticotropin-releasing factor.
    Muret L, Priou A, Oliver C, Grino M.
    Endocrinology; 1992 May 21; 130(5):2725-32. PubMed ID: 1315256
    [Abstract] [Full Text] [Related]

  • 16. The effect of vasopressin 1b receptor (V1bR) blockade on HPA axis activity in rats exposed to acute heat stress.
    Jasnic N, Djordjevic J, Vujovic P, Lakic I, Djurasevic S, Cvijic G.
    J Exp Biol; 2013 Jun 15; 216(Pt 12):2302-7. PubMed ID: 23580725
    [Abstract] [Full Text] [Related]

  • 17. Injection of Urocortin 3 into the ventromedial hypothalamus modulates feeding, blood glucose levels, and hypothalamic POMC gene expression but not the HPA axis.
    Chen P, Vaughan J, Donaldson C, Vale W, Li C.
    Am J Physiol Endocrinol Metab; 2010 Feb 15; 298(2):E337-45. PubMed ID: 19952342
    [Abstract] [Full Text] [Related]

  • 18. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
    Owens MJ, Knight DL, Ritchie JC, Nemeroff CB.
    J Pharmacol Exp Ther; 1991 Feb 15; 256(2):795-800. PubMed ID: 1847213
    [Abstract] [Full Text] [Related]

  • 19. Urocortin is not a significant regulator of intermittent electrofootshock-induced adrenocorticotropin secretion in the intact male rat.
    Turnbull AV, Vaughan J, Rivier JE, Vale WW, Rivier C.
    Endocrinology; 1999 Jan 15; 140(1):71-8. PubMed ID: 9886809
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the 2-deoxyglucose effect on the adrenocortical axis.
    Weidenfeld J, Corcos AP, Wohlman A, Feldman S.
    Endocrinology; 1994 Apr 15; 134(4):1924-31. PubMed ID: 8137760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.